Global Active Pharmaceutical Ingredients (API) Market Research Report 2015-2027 of Major Types, Applications and Competitive Vendors in Top Regions and Countries

Global Active Pharmaceutical Ingredients (API) Market Research Report 2015-2027 of Major Types, Applications and Competitive Vendors in Top Regions and Countries

Reports Details

The Global market for Active Pharmaceutical Ingredients (API) is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach USD X.X million in 2027, from USD X.X million in 2020.

Aimed to provide most segmented consumption and sales data of different types of Active Pharmaceutical Ingredients (API), downstream consumption fields and competitive landscape in different regions and countries around the world, this report analyzes the latest market data from the primary and secondary authoritative source.

The report also tracks the latest market dynamics, such as driving factors, restraining factors, and industry news like mergers, acquisitions, and investments. It provides market size (value and volume), market share, growth rate by types, applications, and combines both qualitative and quantitative methods to make micro and macro forecasts in different regions or countries.

The report can help to understand the market and strategize for business expansion accordingly. In the strategy analysis, it gives insights from marketing channel and market positioning to potential growth strategies, providing in-depth analysis for new entrants or exists competitors in the Active Pharmaceutical Ingredients (API) industry.

The report focuses on the top players in terms of profiles, product analysis, sales, price, revenue, and gross margin.
Major players covered in this report:
Actavis plc
Novartis AG
Dr. Reddy’s Laboratories
BASF SE
Sun Pharmaceutical Industries LTD
Mylan N.V.
Lonza Group
Boehringer Ingelheim GmbH
Pfizer, Inc.
Hospira Inc.
Albemarle Corporation
Fresenius Kabi
Teva Pharmaceutical Industries LTD
Lupin Pharmaceuticals Inc.
Aurobindo Pharma Limited

By Type:
Synthetic Chemical API
Biological API

By Application:
Anti-infectives
Oncology
Cardiovascular and hematopoietic system
Central nervous system
Respiratory system
Gastrointestinal
Hormonal related disorders
Metabolic disorders
Genito-urinary disorders
Musculo-skeletal disorders
Other Therapeutics Uses

Geographically, the regional consumption and value analysis by types, applications, and countries are included in the report. Furthermore, it also introduces the major competitive players in these regions.
Major regions covered in the report:
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa

Country-level segmentation in the report:
United States
Germany
UK
France
Italy
Spain
Poland
Russia
China
Japan
India
Indonesia
Thailand
Philippines
Malaysia
Singapore
Vietnam
Brazil
Saudi Arabia
United Arab Emirates
Qatar
Bahrain

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027

Table of Content

1 Market Overview
1.1 Active Pharmaceutical Ingredients (API) Introduction
1.2 Market Analysis by Type
1.2.1 Synthetic Chemical API
1.2.2 Biological API
1.3 Market Analysis by Application
1.3.1 Anti-infectives
1.3.2 Oncology
1.3.3 Cardiovascular and hematopoietic system
1.3.4 Central nervous system
1.3.5 Respiratory system
1.3.6 Gastrointestinal
1.3.7 Hormonal related disorders
1.3.8 Metabolic disorders
1.3.9 Genito-urinary disorders
1.3.10 Musculo-skeletal disorders
1.3.11 Other Therapeutics Uses
1.4 Market Analysis by Region
1.4.1 United States Market States and Outlook (2015-2027)
1.4.2 Europe Market States and Outlook (2015-2027)
1.4.3 China Market States and Outlook (2015-2027)
1.4.4 Japan Market States and Outlook (2015-2027)
1.4.5 Southeast Asia Market States and Outlook (2015-2027)
1.4.6 India Market States and Outlook (2015-2027)
1.4.7 Brazil Market States and Outlook (2015-2027)
1.4.8 GCC Countries Market States and Outlook (2015-2027)
1.5 Market Dynamics and Development
1.5.1 Merger, Acquisition and New Investment
1.5.2 Market SWOT Analysis
1.5.3 Drivers
1.5.4 Limitations
1.5.5 Opportunities and Development Trends
1.6 Global Active Pharmaceutical Ingredients (API) Market Size Analysis from 2015 to 2027
1.6.1 Global Active Pharmaceutical Ingredients (API) Market Size Analysis from 2015 to 2027 by Consumption Volume
1.6.2 Global Active Pharmaceutical Ingredients (API) Market Size Analysis from 2015 to 2027 by Value
1.6.3 Global Active Pharmaceutical Ingredients (API) Price Trends Analysis from 2015 to 2027

2 Global Active Pharmaceutical Ingredients (API) Competition by Types, Applications, and Top Regions and Countries
2.1 Global Active Pharmaceutical Ingredients (API) (Volume and Value) by Type
2.1.1 Global Active Pharmaceutical Ingredients (API) Consumption and Market Share by Type (2015-2020)
2.1.2 Global Active Pharmaceutical Ingredients (API) Revenue and Market Share by Type (2015-2020)
2.2 Global Active Pharmaceutical Ingredients (API) (Volume and Value) by Application
2.2.1 Global Active Pharmaceutical Ingredients (API) Consumption and Market Share by Application (2015-2020)
2.2.2 Global Active Pharmaceutical Ingredients (API) Revenue and Market Share by Application (2015-2020)
2.3 Global Active Pharmaceutical Ingredients (API) (Volume and Value) by Region
2.3.1 Global Active Pharmaceutical Ingredients (API) Consumption and Market Share by Region (2015-2020)
2.3.2 Global Active Pharmaceutical Ingredients (API) Revenue and Market Share by Region (2015-2020)

3 United States Active Pharmaceutical Ingredients (API) Market Analysis
3.1 United States Active Pharmaceutical Ingredients (API) Consumption and Value Analysis
3.2 United States Active Pharmaceutical Ingredients (API) Consumption Volume by Type
3.3 United States Active Pharmaceutical Ingredients (API) Consumption Structure by Application

4 Europe Active Pharmaceutical Ingredients (API) Market Analysis
4.1 Europe Active Pharmaceutical Ingredients (API) Consumption and Value Analysis
4.2 Europe Active Pharmaceutical Ingredients (API) Consumption Volume by Type
4.3 Europe Active Pharmaceutical Ingredients (API) Consumption Structure by Application
4.4 Europe Active Pharmaceutical Ingredients (API) Consumption by Top Countries
4.4.1 Germany Active Pharmaceutical Ingredients (API) Consumption Volume from 2015 to 2020
4.4.2 UK Active Pharmaceutical Ingredients (API) Consumption Volume from 2015 to 2020
4.4.3 France Active Pharmaceutical Ingredients (API) Consumption Volume from 2015 to 2020
4.4.4 Italy Active Pharmaceutical Ingredients (API) Consumption Volume from 2015 to 2020
4.4.5 Spain Active Pharmaceutical Ingredients (API) Consumption Volume from 2015 to 2020
4.4.6 Poland Active Pharmaceutical Ingredients (API) Consumption Volume from 2015 to 2020
4.4.7 Russia Active Pharmaceutical Ingredients (API) Consumption Volume from 2015 to 2020

5 China Active Pharmaceutical Ingredients (API) Market Analysis
5.1 China Active Pharmaceutical Ingredients (API) Consumption and Value Analysis
5.2 China Active Pharmaceutical Ingredients (API) Consumption Volume by Type
5.3 China Active Pharmaceutical Ingredients (API) Consumption Structure by Application

6 Japan Active Pharmaceutical Ingredients (API) Market Analysis
6.1 Japan Active Pharmaceutical Ingredients (API) Consumption and Value Analysis
6.2 Japan Active Pharmaceutical Ingredients (API) Consumption Volume by Type
6.3 Japan Active Pharmaceutical Ingredients (API) Consumption Structure by Application

7 Southeast Asia Active Pharmaceutical Ingredients (API) Market Analysis
7.1 Southeast Asia Active Pharmaceutical Ingredients (API) Consumption and Value Analysis
7.2 Southeast Asia Active Pharmaceutical Ingredients (API) Consumption Volume by Type
7.3 Southeast Asia Active Pharmaceutical Ingredients (API) Consumption Structure by Application
7.4 Southeast Asia Active Pharmaceutical Ingredients (API) Consumption by Top Countries
7.4.1 Indonesia Active Pharmaceutical Ingredients (API) Consumption Volume from 2015 to 2020
7.4.2 Thailand Active Pharmaceutical Ingredients (API) Consumption Volume from 2015 to 2020
7.4.3 Philippines Active Pharmaceutical Ingredients (API) Consumption Volume from 2015 to 2020
7.4.4 Malaysia Active Pharmaceutical Ingredients (API) Consumption Volume from 2015 to 2020
7.4.5 Singapore Active Pharmaceutical Ingredients (API) Consumption Volume from 2015 to 2020
7.4.6 Vietnam Active Pharmaceutical Ingredients (API) Consumption Volume from 2015 to 2020

8 India Active Pharmaceutical Ingredients (API) Market Analysis
8.1 India Active Pharmaceutical Ingredients (API) Consumption and Value Analysis
8.2 India Active Pharmaceutical Ingredients (API) Consumption Volume by Type
8.3 India Active Pharmaceutical Ingredients (API) Consumption Structure by Application

9 Brazil Active Pharmaceutical Ingredients (API) Market Analysis
9.1 Brazil Active Pharmaceutical Ingredients (API) Consumption and Value Analysis
9.2 Brazil Active Pharmaceutical Ingredients (API) Consumption Volume by Type
9.3 Brazil Active Pharmaceutical Ingredients (API) Consumption Structure by Application

10 GCC Countries Active Pharmaceutical Ingredients (API) Market Analysis
10.1 GCC Countries Active Pharmaceutical Ingredients (API) Consumption and Value Analysis
10.2 GCC Countries Active Pharmaceutical Ingredients (API) Consumption Volume by Type
10.3 GCC Countries Active Pharmaceutical Ingredients (API) Consumption Structure by Application
10.4 GCC Countries Active Pharmaceutical Ingredients (API) Consumption Volume by Major Countries
10.4.1 Saudi Arabia Active Pharmaceutical Ingredients (API) Consumption Volume from 2015 to 2020
10.4.2 United Arab Emirates Active Pharmaceutical Ingredients (API) Consumption Volume from 2015 to 2020
10.4.3 Qatar Active Pharmaceutical Ingredients (API) Consumption Volume from 2015 to 2020
10.4.4 Bahrain Active Pharmaceutical Ingredients (API) Consumption Volume from 2015 to 2020

11 Manufacturers Profiles
11.1 Actavis plc
11.1.1 Business Overview
11.1.2 Products Analysis
11.1.3 Actavis plc Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin
11.1.4 Actavis plc Active Pharmaceutical Ingredients (API) Sales by Region
11.2 Novartis AG
11.2.1 Business Overview
11.2.2 Products Analysis
11.2.3 Novartis AG Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin
11.2.4 Novartis AG Active Pharmaceutical Ingredients (API) Sales by Region
11.3 Dr. Reddy’s Laboratories
11.3.1 Business Overview
11.3.2 Products Analysis
11.3.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin
11.3.4 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Sales by Region
11.4 BASF SE
11.4.1 Business Overview
11.4.2 Products Analysis
11.4.3 BASF SE Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin
11.4.4 BASF SE Active Pharmaceutical Ingredients (API) Sales by Region
11.5 Sun Pharmaceutical Industries LTD
11.5.1 Business Overview
11.5.2 Products Analysis
11.5.3 Sun Pharmaceutical Industries LTD Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin
11.5.4 Sun Pharmaceutical Industries LTD Active Pharmaceutical Ingredients (API) Sales by Region
11.6 Mylan N.V.
11.6.1 Business Overview
11.6.2 Products Analysis
11.6.3 Mylan N.V. Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin
11.6.4 Mylan N.V. Active Pharmaceutical Ingredients (API) Sales by Region
11.7 Lonza Group
11.7.1 Business Overview
11.7.2 Products Analysis
11.7.3 Lonza Group Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin
11.7.4 Lonza Group Active Pharmaceutical Ingredients (API) Sales by Region
11.8 Boehringer Ingelheim GmbH
11.8.1 Business Overview
11.8.2 Products Analysis
11.8.3 Boehringer Ingelheim GmbH Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin
11.8.4 Boehringer Ingelheim GmbH Active Pharmaceutical Ingredients (API) Sales by Region
11.9 Pfizer, Inc.
11.9.1 Business Overview
11.9.2 Products Analysis
11.9.3 Pfizer, Inc. Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin
11.9.4 Pfizer, Inc. Active Pharmaceutical Ingredients (API) Sales by Region
11.10 Hospira Inc.
11.10.1 Business Overview
11.10.2 Products Analysis
11.10.3 Hospira Inc. Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin
11.10.4 Hospira Inc. Active Pharmaceutical Ingredients (API) Sales by Region
11.11 Albemarle Corporation
11.11.1 Business Overview
11.11.2 Products Analysis
11.11.3 Albemarle Corporation Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin
11.11.4 Albemarle Corporation Active Pharmaceutical Ingredients (API) Sales by Region
11.12 Fresenius Kabi
11.12.1 Business Overview
11.12.2 Products Analysis
11.12.3 Fresenius Kabi Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin
11.12.4 Fresenius Kabi Active Pharmaceutical Ingredients (API) Sales by Region
11.13 Teva Pharmaceutical Industries LTD
11.13.1 Business Overview
11.13.2 Products Analysis
11.13.3 Teva Pharmaceutical Industries LTD Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin
11.13.4 Teva Pharmaceutical Industries LTD Active Pharmaceutical Ingredients (API) Sales by Region
11.14 Lupin Pharmaceuticals Inc.
11.14.1 Business Overview
11.14.2 Products Analysis
11.14.3 Lupin Pharmaceuticals Inc. Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin
11.14.4 Lupin Pharmaceuticals Inc. Active Pharmaceutical Ingredients (API) Sales by Region
11.15 Aurobindo Pharma Limited
11.15.1 Business Overview
11.15.2 Products Analysis
11.15.3 Aurobindo Pharma Limited Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin
11.15.4 Aurobindo Pharma Limited Active Pharmaceutical Ingredients (API) Sales by Region

12 Marketing Strategy Analysis
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Global Active Pharmaceutical Ingredients (API) Market Forecast (2020-2027)
13.1 Global Active Pharmaceutical Ingredients (API) Consumption Volume, Revenue and Price Forecast (2020-2027)
13.1.1 Global Active Pharmaceutical Ingredients (API) Consumption Volume and Growth Rate Forecast (2020-2027)
13.1.2 Global Active Pharmaceutical Ingredients (API) Value and Growth Rate Forecast (2020-2027)
13.1.3 Global Active Pharmaceutical Ingredients (API) Price and Trend Forecast (2020-2027)
13.2 Global Active Pharmaceutical Ingredients (API) Consumption Volume, Value and Growth Rate Forecast by Region (2020-2027)
13.2.1 Global Active Pharmaceutical Ingredients (API) Consumption Volume and Growth Rate Forecast by Region (2020-2027)
13.2.2 Global Active Pharmaceutical Ingredients (API) Value and Growth Rate Forecast by Region (2020-2027)
13.3 Global Active Pharmaceutical Ingredients (API) Consumption Volume, Revenue and Price Forecast by Type (2020-2027)
13.3.1 Global Active Pharmaceutical Ingredients (API) Consumption Forecast by Type (2020-2027)
13.3.2 Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Type (2020-2027)
13.3.3 Global Active Pharmaceutical Ingredients (API) Price Forecast by Type (2020-2027)
13.4 Global Active Pharmaceutical Ingredients (API) Consumption Volume Forecast by Application (2020-2027)

14 Research Conclusions

15 Appendix
15.1 Methodology
15.2 Research Data Source

Request Sample



captcha




$3,960.00$5,200.00

Clear
About this Report
SKU: C1630 Category:
Share this report

About ReportsCheck

ReportsCheck is a one-stop platform that offers market research and business consulting services to various industries located globally. The market intelligence data is offered to all micro, medium and top-tier companies. We offer premium statistical analysis, global, regional and country-level reports with forecast data for companies across the globe.

Copyright © 2019, ReportsCheck – Market Research Reports. All Rights reserved.

Powered by ReportsCheck